|
G |
CXCL10 |
C-X-C motif chemokine ligand 10 |
increases expression |
EXP |
KRN 7000 results in increased expression of CXCL10 protein |
CTD |
PMID:15867097 |
|
NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497
|
|
G |
IL12B |
interleukin 12B |
increases expression |
EXP |
KRN 7000 results in increased expression of IL12B protein |
CTD |
PMID:15867097 |
|
NCBI chr 5:159,314,780...159,330,487
Ensembl chr 5:159,314,780...159,330,863
|
|
|
G |
GATA3 |
GATA binding protein 3 |
multiple interactions |
ISO |
[Ovalbumin co-treated with alpha-galactosylceramide] results in decreased expression of GATA3 mRNA |
CTD |
PMID:30803854 |
|
NCBI chr10:8,045,333...8,075,198
Ensembl chr10:8,045,378...8,075,198
|
|
G |
GPT |
glutamic--pyruvic transaminase |
multiple interactions |
ISO |
[Floxacillin co-treated with alpha-galactosylceramide] results in increased expression of GPT protein |
CTD |
PMID:30993380 |
|
NCBI chr 8:144,503,068...144,507,172
Ensembl chr 8:144,502,973...144,507,174
|
|
G |
IFNG |
interferon gamma |
multiple interactions increases secretion |
ISO |
[Alcohols co-treated with alpha-galactosylceramide] results in increased expression of IFNG protein; [Ovalbumin co-treated with alpha-galactosylceramide] results in increased secretion of IFNG protein alpha-galactosylceramide results in increased secretion of IFNG protein |
CTD |
PMID:12482940 PMID:25499027 PMID:30803854 |
|
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
|
|
G |
IL10 |
interleukin 10 |
multiple interactions |
ISO |
[Ovalbumin co-treated with alpha-galactosylceramide] results in decreased secretion of IL10 protein |
CTD |
PMID:30803854 |
|
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
|
|
G |
IL13 |
interleukin 13 |
multiple interactions |
ISO |
[Ovalbumin co-treated with alpha-galactosylceramide] results in decreased secretion of IL13 protein |
CTD |
PMID:30803854 |
|
NCBI chr 5:132,656,522...132,661,110
Ensembl chr 5:132,656,263...132,661,110
|
|
G |
IL17A |
interleukin 17A |
multiple interactions |
ISO |
[Ovalbumin co-treated with alpha-galactosylceramide] results in decreased secretion of IL17A protein |
CTD |
PMID:30803854 |
|
NCBI chr 6:52,186,375...52,190,638
Ensembl chr 6:52,186,375...52,190,638
|
|
G |
IL4 |
interleukin 4 |
increases secretion multiple interactions |
ISO |
alpha-galactosylceramide results in increased secretion of IL4 protein [Ovalbumin co-treated with alpha-galactosylceramide] results in decreased secretion of IL4 protein |
CTD |
PMID:12482940 PMID:30803854 |
|
NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
|
|
G |
IL5 |
interleukin 5 |
multiple interactions |
ISO |
[Ovalbumin co-treated with alpha-galactosylceramide] results in decreased secretion of IL5 protein |
CTD |
PMID:30803854 |
|
NCBI chr 5:132,541,445...132,556,815
Ensembl chr 5:132,541,445...132,556,838
|
|
G |
KLRF2 |
killer cell lectin like receptor F2 |
decreases expression |
ISO |
alpha-galactosylceramide results in decreased expression of KLRB1C protein |
CTD |
PMID:30993380 |
|
NCBI chr12:9,881,489...9,895,833
Ensembl chr12:9,881,489...9,895,833
|
|
G |
RORC |
RAR related orphan receptor C |
multiple interactions |
ISO |
[Ovalbumin co-treated with alpha-galactosylceramide] results in decreased expression of RORC mRNA alternative form |
CTD |
PMID:30803854 |
|
NCBI chr 1:151,806,071...151,831,802
Ensembl chr 1:151,806,071...151,831,845
|
|
G |
TBX21 |
T-box transcription factor 21 |
multiple interactions |
ISO |
[Ovalbumin co-treated with alpha-galactosylceramide] results in increased expression of TBX21 mRNA |
CTD |
PMID:30803854 |
|
NCBI chr17:47,733,236...47,746,122
Ensembl chr17:47,733,236...47,746,122
|
|
|
G |
AIFM1 |
apoptosis inducing factor mitochondria associated 1 |
affects localization multiple interactions |
EXP |
phytosphingosine affects the localization of AIFM1 protein 3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2H)-isoquinolinone inhibits the reaction [phytosphingosine affects the localization of AIFM1 protein] |
CTD |
PMID:15486061 |
|
NCBI chr X:130,129,362...130,165,841
Ensembl chr X:130,124,666...130,165,879
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
multiple interactions increases expression affects localization |
EXP |
3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2H)-isoquinolinone inhibits the reaction [[arsenic trioxide co-treated with phytosphingosine] results in increased localization of BAX protein]; [arsenic trioxide co-treated with phytosphingosine] results in increased localization of BAX protein; Acetylcysteine inhibits the reaction [[arsenic trioxide co-treated with phytosphingosine] results in increased localization of BAX protein]; SB 203580 inhibits the reaction [[arsenic trioxide co-treated with phytosphingosine] results in increased localization of BAX protein] phytosphingosine results in increased expression of BAX protein phytosphingosine affects the localization of BAX protein |
CTD |
PMID:15486061 PMID:17237268 PMID:36334778 PMID:37956922 |
|
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
increases expression |
EXP |
phytosphingosine results in increased expression of BCL2 protein |
CTD |
PMID:36334778 |
|
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
G |
CASP3 |
caspase 3 |
multiple interactions increases expression |
EXP |
3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2H)-isoquinolinone inhibits the reaction [[Arsenic Trioxide co-treated with phytosphingosine] results in increased activity of CASP3 protein]; [Arsenic Trioxide co-treated with phytosphingosine] results in increased activity of CASP3 protein; phytosphingosine results in increased expression of and results in increased cleavage of CASP3 protein; SB 203580 inhibits the reaction [[Arsenic Trioxide co-treated with phytosphingosine] results in increased activity of CASP3 protein] phytosphingosine results in increased expression of CASP3 protein |
CTD |
PMID:17237268 PMID:36334778 PMID:37956922 |
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CASP9 |
caspase 9 |
multiple interactions increases expression |
EXP |
3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2H)-isoquinolinone inhibits the reaction [[arsenic trioxide co-treated with phytosphingosine] results in increased activity of CASP9 protein]; [arsenic trioxide co-treated with phytosphingosine] results in increased activity of CASP9 protein; SB 203580 inhibits the reaction [[arsenic trioxide co-treated with phytosphingosine] results in increased activity of CASP9 protein] phytosphingosine results in increased expression of CASP9 protein |
CTD |
PMID:17237268 PMID:37956922 |
|
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
|
|
G |
CCNB1 |
cyclin B1 |
decreases expression |
EXP |
phytosphingosine results in decreased expression of CCNB1 protein |
CTD |
PMID:37956922 |
|
NCBI chr 5:69,167,150...69,178,245
Ensembl chr 5:69,167,135...69,178,245
|
|
G |
CDK1 |
cyclin dependent kinase 1 |
decreases expression |
EXP |
phytosphingosine results in decreased expression of CDK1 protein |
CTD |
PMID:37956922 |
|
NCBI chr10:60,778,331...60,794,852
Ensembl chr10:60,778,331...60,794,852
|
|
G |
CYCS |
cytochrome c, somatic |
increases expression |
EXP |
phytosphingosine results in increased expression of CYCS protein |
CTD |
PMID:36334778 |
|
NCBI chr 7:25,118,656...25,125,260
Ensembl chr 7:25,118,656...25,125,260
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
multiple interactions |
EXP |
[arsenic trioxide co-treated with phytosphingosine] results in decreased phosphorylation of MAPK1 protein |
CTD |
PMID:17237268 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK14 |
mitogen-activated protein kinase 14 |
multiple interactions |
EXP |
3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2H)-isoquinolinone inhibits the reaction [[arsenic trioxide co-treated with phytosphingosine] results in increased phosphorylation of MAPK14 protein]; [arsenic trioxide co-treated with phytosphingosine] results in increased phosphorylation of MAPK14 protein; Acetylcysteine inhibits the reaction [[arsenic trioxide co-treated with phytosphingosine] results in increased phosphorylation of MAPK14 protein] |
CTD |
PMID:17237268 |
|
NCBI chr 6:36,027,808...36,124,214
Ensembl chr 6:36,027,782...36,111,236
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
multiple interactions |
EXP |
[arsenic trioxide co-treated with phytosphingosine] results in decreased phosphorylation of MAPK3 protein |
CTD |
PMID:17237268 |
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
PARP1 |
poly(ADP-ribose) polymerase 1 |
multiple interactions increases cleavage increases activity |
EXP |
3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2H)-isoquinolinone inhibits the reaction [[Arsenic Trioxide co-treated with phytosphingosine] results in increased activity of PARP1 protein]; [Arsenic Trioxide co-treated with phytosphingosine] results in increased activity of PARP1 protein; [Arsenic Trioxide co-treated with phytosphingosine] results in increased cleavage of PARP1 protein; Acetylcysteine inhibits the reaction [[Arsenic Trioxide co-treated with phytosphingosine] results in increased activity of PARP1 protein] phytosphingosine results in increased cleavage of PARP1 protein phytosphingosine results in increased activity of PARP1 protein |
CTD |
PMID:15486061 PMID:17237268 PMID:37956922 |
|
NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
|
|
G |
PINK1 |
PTEN induced kinase 1 |
decreases expression |
EXP |
phytosphingosine results in decreased expression of PINK1 protein |
CTD |
PMID:36334778 |
|
NCBI chr 1:20,633,458...20,651,511
Ensembl chr 1:20,633,458...20,651,511
|
|